2Laine L.Proton pump inhibitor co-therapy with nonsteroidal antiinflammatory drugs-nice or necessary?.Bey Castroenterol Disord,2004,4(Suppl 4):S33-41.
3Bardhan KD.Bjrnason I,Scott DL,et al.The prevention and healing of acute NSAID associated gastreduodenalmucosal damage by misoprostol.Br J Rheumatol,1993,32(11):990-995.
4Taha AS,Dahill S,Sturrock RD,et al.Predicting NSAID related ulcers assessment of clinical and pathological risk factors and importance of differences in NSAID.Gut,1994,35(7):891-895.
5Dijkmans BA,Janssen M,Vandenbroucke JP,et al.NSAID associated upper gastrointestinal damage in patients with rheumatoid arthritis.Scand J Gastroenterol Suppl,1995,30(212):105-108.
6Cappell MS,Schein JR.Diagnosis and treatment of nonsteroidal antiinflammatory drug-associated upper gastrointestinal toxicity.Gastroemerol Clin North Am,2000,29(1):97-124.
7Voutilainen M,Sokka T,Juhola M.Nonsteroidalant-inflammatory drug-associated upper gastroin-testinal lesions in rheumatoid arthritis patients.Relationships to gastrichistology Helicobactor Pylori infection,and other risk factors for peptieulcer.ScandJ Gastroenterol,1998,33(8):811-816.
8Aalykke C,Lauritsen Ji,Hallas J.Helicobacter pylor and risk of ulcer bleeding among users of nonsteroidalanti-inflammatory drugs:a case-control study.Gastroenterology,1999,116(6):13059-1309.
9Lanas A,Scheiman J.Low-dose aspirin and upper gastrointestinal damage:epidemiology,prevention and treatment.Curr Med Res Opin,2007,23(1):163-173.
